Elucidation of the Intestinal Absorption Mechanism of Loganin in the Human Intestinal Caco-2 Cell Model
- PMID: 30671130
- PMCID: PMC6323428
- DOI: 10.1155/2018/8340563
Elucidation of the Intestinal Absorption Mechanism of Loganin in the Human Intestinal Caco-2 Cell Model
Abstract
Loganin, iridoid glycosides, is the main bioactive ingredients in the plant Strychnos nux-vomica L. and demonstrates various pharmacological effects, though poor oral bioavailability in rats. In this study, the intestinal absorption mechanism of loganin was investigated using the human intestinal Caco-2 cell monolayer model in both the apical-to-basolateral (A-B) and the basolateral-to-apical (B-A) direction; additionally, transport characteristics were systematically investigated at different concentrations, pHs, temperatures, and potential transporters. The absorption permeability (PappAB) of loganin, which ranged from 12.17 to 14.78 × 10-6cm/s, was high at four tested concentrations (5, 20, 40, and 80μM), while the major permeation mechanism of loganin was found to be passive diffusion with active efflux mediated by multidrug resistance-associated protein (MRP) and breast cancer resistance protein (BCRP). In addition, it was found that loganin was not the substrate of efflux transporter P-glycoprotein (P-gp) since the selective inhibitor (verapamil) of the efflux transporter exhibited little effects on the transport of loganin in the human intestinal Caco-2 cells. Meanwhile, transport from the apical to the basolateral side increased 2.09-fold after addition of a MRP inhibitor and 2.32-fold after addition of a BCRP inhibitor. In summary, our results clearly demonstrate, for the first time, a good permeability of loganin in the human intestinal Caco-2 cell model and elucidate, in detail, the intestinal absorption mechanism and the effects of transporters on iridoid glycosides compounds.
Figures




Similar articles
-
Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7. doi: 10.1152/ajpgi.00102.2009. Epub 2009 Jun 18. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19541926
-
Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.Pharm Res. 1998 Aug;15(8):1160-7. doi: 10.1023/a:1011971303880. Pharm Res. 1998. PMID: 9706044
-
Study on the mechanism of intestinal absorption of epimedins a, B and C in the Caco-2 cell model.Molecules. 2014 Jan 7;19(1):686-98. doi: 10.3390/molecules19010686. Molecules. 2014. PMID: 24402200 Free PMC article.
-
Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.Mol Pharm. 2013 May 6;10(5):1783-94. doi: 10.1021/mp300582s. Epub 2013 Apr 24. Mol Pharm. 2013. PMID: 23560393
-
Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery.Pharmaceutics. 2022 May 26;14(6):1131. doi: 10.3390/pharmaceutics14061131. Pharmaceutics. 2022. PMID: 35745704 Free PMC article. Review.
Cited by
-
Loganetin and 5-fluorouracil synergistically inhibit the carcinogenesis of gastric cancer cells via down-regulation of the Wnt/β-catenin pathway.J Cell Mol Med. 2020 Dec;24(23):13715-13726. doi: 10.1111/jcmm.15932. Epub 2020 Oct 24. J Cell Mol Med. 2020. PMID: 33098378 Free PMC article.
-
Lipid-lowering effect and oral transport characteristics study of curculigoside.Front Cardiovasc Med. 2024 Jul 2;11:1426379. doi: 10.3389/fcvm.2024.1426379. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39015683 Free PMC article.
-
Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.Inflamm Res. 2021 Jul;70(7):753-764. doi: 10.1007/s00011-021-01482-x. Epub 2021 Jul 1. Inflamm Res. 2021. PMID: 34212215 Review.
-
Natural Plant Extract - Loganin: A Hypothesis for Psoriasis Treatment Through Inhibiting Oxidative Stress and Equilibrating Immunity via Regulation of Macrophage Polarization.Clin Cosmet Investig Dermatol. 2023 Feb 13;16:407-417. doi: 10.2147/CCID.S396173. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 36817639 Free PMC article.
-
Characterization of the intestinal absorption of morroniside from Cornus officinalis Sieb. et Zucc via a Caco-2 cell monolayer model.PLoS One. 2020 May 29;15(5):e0227844. doi: 10.1371/journal.pone.0227844. eCollection 2020. PLoS One. 2020. PMID: 32470043 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous